SCHEMBL2905900

SCHEMBL2905900

CCCCC/C=C\C/C=C\C(CCCCCCC(=O)OCCO)CC(O)CO

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.62
FAAH O00519 4/20 0.57
DGKA P23743 1/20 0.57
SELP P16109 1/20 0.52
ALDH1A1 P00352 1/20 0.49
MAPT P10636 1/20 0.49
THRB P10828 1/20 0.49
CNR1 P21554 1/20 0.49
LPAR1 Q92633 6/20 0.47
LPAR4 Q99677 3/20 0.47
LPAR2 Q9HBW0 3/20 0.47
LPAR3 Q9UBY5 3/20 0.47
EPHX2 P34913 1/20 0.47
ENPP2 Q13822 2/20 0.47
LPAR5 Q9H1C0 2/20 0.47
CES2 O00748 1/20 0.47
LPAR6 P43657 1/20 0.47
TRPV1 Q8NER1 1/20 0.47
PRKCE Q02156 1/20 0.47
PRKCQ Q04759 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5052012 0.89 FAAH (0.62) FAAHDGKASELPMAPTLPAR1
SCHEMBL7128696 0.85 MGLL (0.65) MGLLFAAHDGKASELPALDH1A1
SCHEMBL17685834 0.82 MGLL (0.91) MGLLFAAHDGKAALDH1A1MAPT
SCHEMBL3280959 0.82 MGLL (0.91) MGLLFAAHDGKAALDH1A1MAPT
SCHEMBL29513053 0.81 MGLL (0.94) MGLLFAAHDGKAALDH1A1MAPT
SCHEMBL1462396 0.81 DGKA (0.57) MGLLFAAHDGKALPAR1LPAR4
Ethylene SCHEMBL9014239 0.80 MGLL (0.86) MGLLFAAHDGKAALDH1A1MAPT
SCHEMBL28759495 0.80 FAAH (0.64) MGLLFAAHDGKASELPALDH1A1
SCHEMBL142809 0.79 FFAR1 (0.66) MGLLFAAHDGKALPAR1LPAR4
SCHEMBL27513328 0.79 FFAR1 (0.66) MGLLFAAHDGKALPAR1LPAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080279914-A1 Transdermal composition comprising piroxicam-inorganic material complex and patch system comprising the same SK HOLDINGS CO, LTD. (KR) 2008-11-13 US claimed
US-10758546-B2 Transdermal delivery system containing galantamine or salts thereof INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2020-09-01 US disclosed
EP-2676663-B1 TRANSDERMAL DELIVERY SYSTEM CONTAINING GALANTAMINE OR SALTS THEREOF UNIV CHOSUN IACF (KR) 2018-05-23 EP disclosed
US-20160339038-A1 TRANSDERMAL DELIVERY SYSTEM CONTAINING GALANTAMINE OR SALTS THEREOF INDUSTRY-ACADEMIC COOP FOUND CHOSUN UNIV (KR) 2016-11-24 US disclosed
US-9066886-B2 Transdermal drug delivery system containing granisetron TAHO PHARMACEUTICALS, LTD. (TW) 2015-06-30 US disclosed
EP-2676663-A2 TRANSDERMAL DELIVERY SYSTEM CONTAINING GALANTAMINE OR SALTS THEREOF Industry-academic Cooperation Foundation, Chosun University (KR) 2013-12-25 EP disclosed
US-20130324950-A1 TRANSDERMAL DELIVERY SYSTEM CONTAINING GALANTAMINE OR SALTS THEREOF INDUSTRY-ACADEMIC COOPERATION FOUNDATION, CHOSUN UNIVERSITY (KR) 2013-12-05 US disclosed
US-20100285133-A1 TRANSDERMAL DRUG DELIVERY SYSTEM CONTAINING GRANISETRON ECHO PACIFIC LTD. (CN) 2010-11-11 US disclosed
US-20080279914-A1 Transdermal composition comprising piroxicam-inorganic material complex and patch system comprising the same SK HOLDINGS CO, LTD. (KR) 2008-11-13 US disclosed